Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1986 1
1987 1
1988 3
1989 3
1990 1
1991 4
1993 1
2000 1
2002 4
2003 1
2004 1
2005 3
2006 8
2007 3
2008 11
2009 4
2010 3
2011 11
2012 7
2013 6
2014 11
2015 13
2016 11
2017 13
2018 7
2019 8
2020 16
2021 8
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Results by year
Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Dimopoulos MA, Oriol A, Nahi H, San-Miguel J, Bahlis NJ, Usmani SZ, Rabin N, Orlowski RZ, Komarnicki M, Suzuki K, Plesner T, Yoon SS, Ben Yehuda D, Richardson PG, Goldschmidt H, Reece D, Lisby S, Khokhar NZ, O'Rourke L, Chiu C, Qin X, Guckert M, Ahmadi T, Moreau P; POLLUX Investigators. Dimopoulos MA, et al. N Engl J Med. 2016 Oct 6;375(14):1319-1331. doi: 10.1056/NEJMoa1607751. N Engl J Med. 2016. PMID: 27705267 Free article. Clinical Trial.
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.
Rosiñol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hernández MT, Martínez-Martínez R, Moraleda JM, Jarque I, Bargay J, Gironella M, de Arriba F, Palomera L, González-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, González AP, Casado LF, López-Anglada L, Paiva B, Mateos MV, San Miguel JF, Lahuerta JJ, Bladé J. Rosiñol L, et al. Among authors: hernandez mt. Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241. Blood. 2019. PMID: 31484647 Free PMC article. Clinical Trial.
Gaceta Sanitaria en 2020. Respuesta editorial a la sindemia e implementación de nuevas normas.
Hernández MN, Bermúdez-Tamayo C, Alguacil J, Cantarero D, Portiño MC, Casino G, Santillán A, Calvente MG, Epstein D, Hernan M, García LP, Cantero MTR, Segura A, Amez JG, Cairo LAJHY, Miranda JJ, Tejero MF, March JC, Mar J, Peiro R, Álvarez-Dardet C. Hernández MN, et al. Gac Sanit. 2021 Mar-Apr;35(2):109-112. doi: 10.1016/j.gaceta.2021.02.002. Gac Sanit. 2021. PMID: 33632519 Free PMC article. Spanish. No abstract available.
ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME, Hernández MI, Gómez-Gallegos ÁA, Ortiz-Sánchez E. Toledo-Guzmán ME, et al. Among authors: hernandez mi. Curr Stem Cell Res Ther. 2019;14(5):375-388. doi: 10.2174/1574888X13666180810120012. Curr Stem Cell Res Ther. 2019. PMID: 30095061 Review.
Gaceta Sanitaria en 2019. Trabajando para mejorar la eficiencia en la publicación científica.
Bermúdez-Tamayo C, Hernández MN, Alguacil J, Briones-Vozmediano E, Cantarero D, Portiño MC, Casino G, Santillán-García A, Calvente MDMG, Zapata LIG, Epstein D, Hernán M, García LP, Cantero MTR, Segura A, Zunzunegui MV, Juárez L, Miranda JJ, Mar J, Peiró R, Amez JG, Álvarez-Dardet C. Bermúdez-Tamayo C, et al. Among authors: hernandez mn. Gac Sanit. 2020 Mar-Apr;34(2):101-104. doi: 10.1016/j.gaceta.2020.02.001. Gac Sanit. 2020. PMID: 32151337 Free article. Spanish. No abstract available.
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
Medina A, Puig N, Flores-Montero J, Jimenez C, Sarasquete ME, Garcia-Alvarez M, Prieto-Conde I, Chillon C, Alcoceba M, Gutierrez NC, Oriol A, Rosinol L, Bladè J, Gironella M, Hernandez MT, Gonzalez-Calle V, Cedena MT, Paiva B, San-Miguel JF, Lahuerta JJ, Mateos MV, Martinez-Lopez J, Orfao A, Gonzalez M, Garcia-Sanz R. Medina A, et al. Among authors: hernandez mt. Blood Cancer J. 2020 Oct 30;10(10):108. doi: 10.1038/s41408-020-00377-0. Blood Cancer J. 2020. PMID: 33127891 Free PMC article. Clinical Trial.
153 results